Octreotide Injection, Solution
Product Images NDC 63323-377

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Octreotide (NDC 63323-377). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oct04 0000 01

Oct04 0000 01
The text appears to be a chemical formula for a peptide consisting of amino acids. However, without the full context or additional information, it is difficult to provide a more specific description or explanation.*
FDA Label Image

Oct04 0000 02

FDA Label Image

Oct04 0000 03

Oct04 0000 03
This is a description of a medication called Octreotide Acetate Injection with a concentration of 100 mcg (base) per mL. The injection is designed for subcutaneous use and comes in a single-dose vial labeled Rxonly. The manufacturer of the medication is Fresenius Kabi, and the lot number is 402960A. The vial should be discarded if any of the medication remains unused, and it should always be protected from light. There is no preservative in this medication. However, the remainder of the text is unreadable.*
FDA Label Image

Oct04 0000 04

Oct04 0000 04
This is a description of a medicine called Octreotide Acetate Injection, which is for subcutaneous injection only and comes in a single-dose vial of 1 mL. The medicine contains 100 mcg (base) per mL and is prescribed for therapeutic purposes only as indicated by the label "Rx only." The text also includes a sequence of seemingly random characters, which are not relevant to the description.*
FDA Label Image

Oct04 0000 05

Oct04 0000 05
This is a drug information label for Octreotide Acetate Injection, manufactured by Fresenius Kabi, which is a prescription-only medicine given for subcutaneous injection. Each mL of this injection contains 500mcg of Octreotide Acetate. The content comes in the form of a single-dose vial without preservatives, and any unused portions should be discarded. The manufacturer must store the injection away from light. The product was manufactured in Lake Zurich, IL 60047, and the lot number is 402961A.*
FDA Label Image

Oct04 0000 06

Oct04 0000 06
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.